UK regulator approves Pfizer’s hair loss drug Therapeutics The drug, branded as Litfulo, has been approved by UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata. Read more November 1, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2023/10/Pfizer-logo-2023.jpg 500 800 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-11-01 07:39:352023-11-01 09:32:33UK regulator approves Pfizer's hair loss drug
